Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-02Clinical Trial Update: Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures [Phase 2]
Phase 2 trial targeting MDMD and PD-1 in tumors with tertiary lymphoid structures has been withdrawn; the study covered soft tissue sarcoma,…
-
CLINICAL_TRIALS withdrawal · 2025-07-24Clinical Trial Update: A Trial of SHR1258 in Patients With Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial of SHR1258 for biliary tract cancer has been withdrawn by the sponsor.
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 neoadjuvant trial of tremelimumab and durvalumab with gemcitabine/cisplatin for intrahepatic cholangiocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-12-14Clinical Trial Update: A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 [Phase 3]
A Phase 3 trial of SPARC1507 in advanced biliary tract cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-23Clinical Trial Update: Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 study of Varlitinib plus Capecitabine for advanced or metastatic biliary tract cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.